entertainment -WSS

entertainment

author：fashion 2025-09-02 17:34:39 - browse：58874

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： In science, is the line between industry and academia shifting?

hotspot

WSS

When a patient nears the end, a feared therapy can comfort

Why more medical students aren't specializing in primary care

'CMA Fest' 2023: How to watch, who is performing and more

Telehealth startups are trying to fill the menopause care vacuum

How a Boston hospital is priming medical residents to use GPT

How to make AI work for medicine

entertainment

entertainment

explore

Medical leaders decry Supreme Court decision on affirmative action

In science, is the line between industry and academia shifting?

Apple is now the first public company to be valued at $3 trillion

Caribou posts encouraging results on off

Cancer drug shortages should be causing more outrage

Drug firms test therapies to halt Alzheimer’s before symptoms arise

How to save PrEP access — and even expand it

Caribou posts encouraging results on off

Peter Hotez and the public health issue of online harassment

FDA panel gives mixed vote on blood pressure devices

focus

Departing Stanford president retracts two papers

There’s a way to spot data fakery. All journals should be using it

Delta passengers in Vegas fall sick while waiting on flight in triple

Delta passengers in Vegas fall sick while waiting on flight in triple

US jobless claims fall again as labor market continues to flash strength

In science, is the line between industry and academia shifting?

Wikipedia

explore

hotspot

Wikipedia